Contact the Editorial Desk

Writing in

AgeDefy Peptide is glad to hear about the record itself: a citation we quoted wrong, a regulatory reference that has aged out, or a peer-reviewed study on NAD+, MOTS-c, or nearby longevity biology that ought to join the references page. Fixes that sharpen the accuracy of the summaries are the most valuable notes that arrive, and they are read with attention.

The easiest messages to act on pin down three things: the page in question, the exact passage at issue, and the reference behind it — a DOI or PubMed ID wherever you have one. With that in hand a proposed change can be checked against its source directly.

Editorial mailbox: editors@agedefypeptide.com

Outside the remit

A few things sit outside what the site can take on — flagged here so no message waits on an answer it will never get. AgeDefy Peptide reads and summarizes literature; it is not a clinic and not a seller, so it cannot:

• Weigh in on, endorse, or coach human use of any molecule covered here.
• Name a dose, schedule, or route for any particular individual.
• Diagnose a condition or decide whether a given finding fits a given person.
• Sell, locate, recommend, or help you obtain any compound, supplement, or IV therapy from any supplier.
• Field anti-doping questions from athletes about MOTS-c or any other banned substance.

Anyone after medical guidance should see a licensed clinician in their own jurisdiction. Replies to correspondence are not promised and can lag; the mailbox is checked now and then.